L. Banken

发表

Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer

P. Klein, R. Bruno, G. Liebérman, 2005, Cancer Chemotherapy and Pharmacology.

Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

B. Reigner, C. Poole, C. Twelves, 2002, Cancer Chemotherapy and Pharmacology.

Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis.

L. Banken, J. Rowland, R. Jain, 2001, Rheumatology.

The Effect of Aleglitazar on the Pharmacokinetics and Pharmacodynamics of S- and R-Warfarin in Healthy Male Subjects

P. Sanwald-Ducray, C. Jamois, L. Banken, 2014, Journal of cardiovascular pharmacology.

Mibefradil pharmacokinetic and pharmacodynamic population analysis.

L. Banken, H. Welker, 1998, International journal of clinical pharmacology research.

Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites.

B. Reigner, C. Twelves, J. Cassidy, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Effects of Ro 40-5967, a Novel Calcium Antagonist, on Myocardial Function During Ischemia Induced by Lowering Coronary Perfusion Pressure in Dogs: Comparison with Verapamil

J. Clozel, L. Banken, W. Osterrieder, 1989, Journal of cardiovascular pharmacology.

Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive Volunteers

L. Banken, F. Brown, Kay Saywell, 1999, Clinical pharmacokinetics.

Aprotinin: an antidote for recombinant tissue-type plasminogen activator (rt-PA) active in vivo.

S. Roux, J. Clozel, L. Banken, 1990, Journal of the American College of Cardiology.

Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients

B. Reigner, D. Jodrell, J. Cassidy, 1999, Cancer Chemotherapy and Pharmacology.

Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.

C. Hofmann, M. Martin-Facklam, L. Banken, 2012, Clinical therapeutics.

Effects of Ro 40-5967, a new calcium antagonist, and enalapril on cardiac remodeling in renal hypertensive rats.

J. Ménard, D. Heudes, M. Véniant, 1993, Journal of cardiovascular pharmacology.

Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

J. Rabkin, R. Merion, M. Pescovitz, 2000, Antimicrobial Agents and Chemotherapy.

Moclobemide: relationships between dose, drug concentration in plasma, and occurrence of adverse events.

N. Holford, T. Guentert, L. Banken, 1995, Journal of clinical psychopharmacology.

Absence of an interaction between iron and mycophenolate mofetil absorption.

B. Boutouyrie, L. Banken, P. Ducray, 2006, British journal of clinical pharmacology.

Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone

J. Steimer, K. Jorga, L. Banken, 2000, Clinical pharmacology and therapeutics.

Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies.

J. Steimer, K. Jorga, L. Banken, 2000, British journal of clinical pharmacology.

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

B. Reigner, S. Durston, J. Cassidy, 2000, Cancer Chemotherapy and Pharmacology.

Single Ascending Dose Tolerability, Pharmacokinetic–Pharmacodynamic Study of Dihydropyrimidine Dehydrogenase Inhibitor Ro 09-4889

G. Milano, S. Nave, E. Chamorey, 2004, Clinical Cancer Research.

Multiple intravenous dose pharmacokinetic study of carumonam in healthy subjects.

R. Portmann, I. Patel, E. Weidekamm, 1989, Journal of Antimicrobial Chemotherapy.

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.

B. Reigner, J. Verweij, B. Osterwalder, 1998, Clinical Cancer Research.

Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor.

N. Holford, J. Dingemanse, T. Guentert, 1994, British journal of clinical pharmacology.

Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects.

P. Oxley, L. Banken, H. Birnboeck, 2005, International journal of clinical pharmacology and therapeutics.

Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil

B. Reigner, D. Bentley, R. Hughes, 2019, International journal of clinical pharmacology and therapeutics.

Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo‐Controlled Clinical Study

P. Sanwald-Ducray, X. L. D’ardhuy, X. Liogier d’Ardhuy, 2010, Clinical pharmacology and therapeutics.

Effects of Cytochrome P450 3A4 Inhibitors—Ketoconazole and Erythromycin—on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions

N. Parrott, D. Hainzl, C. Hofmann, 2016, Clinical Pharmacokinetics.

Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer.

J. Baselga, B. Leyland-Jones, M. Marty, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Equivalent Pharmacokinetics of Mycophenolate Mofetil in African‐American and Caucasian Male and Female Stable Renal Allograft Recipients

M. Pescovitz, S. Tomlanovich, G. Bumgardner, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects

K. Bogman, N. Parrott, M. Martin-Facklam, 2017, Clinical pharmacology in drug development.

Effect of the Endothelin‐Receptor Antagonist Bosentan on the Pharmacokinetics and Pharmacodynamics of Warfarin

C. Weber, L. Banken, H. Birnboeck, 1999, Journal of clinical pharmacology.

Thorough QT/QTc study of tocilizumab after single-dose administration at therapeutic and supratherapeutic doses in healthy subjects.

B. Kuhn, C. Schmitt, L. Banken, 2011, International journal of clinical pharmacology and therapeutics.

UNALTERED IBUPROFEN-INDUCED FAECAL BLOOD LOSS UPON COADMINISTRATION OF MOCLOBEMIDE

J. Dingemanse, M. Schmitt, J. Jonkman, 1992, Drug metabolism and drug interactions.

Reply to S.M. Ali et al

J. Baselga, B. Leyland-Jones, M. Marty, 2009 .

The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects.

S. Nave, C. Weber, L. Banken, 1999, British journal of clinical pharmacology.

Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients

B. Reigner, K. O'Byrne, D. Cameron, 1999, Cancer Chemotherapy and Pharmacology.

Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.

P. Fontoura, L. Santarelli, J. Quiroz, 2016, JAMA psychiatry.

Relative bioavailability of oral dosage forms of tenoxicam.

T. Guentert, M. Schmitt, R. Defoin, 1994, Arzneimittel-Forschung.

P.2.f.027 The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study

P. Fontoura, L. Santarelli, J. Quiroz, 2014, European Neuropsychopharmacology.

Lack of Interaction between Tolcapone and Tolbutamide in Healthy Volunteers

R. Gasser, K. Jorga, L. Banken, 2000, Journal of clinical pharmacology.

Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

J. Rabkin, R. Merion, M. Pescovitz, 2000, Antimicrobial Agents and Chemotherapy.